The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Orion
Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (Pts) with nonmetastatic castrate-resistant prostate cancer (nmCRPC).
 
Karim Fizazi
Honoraria - Astellas Pharma; Janssen; Merck; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Curevac; ESSA; Janssen Oncology; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen; Janssen
 
Neal D. Shore
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Teuvo Tammela
No Relationships to Disclose
 
Iris Kuss
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Marie-Aude Le Berre
Employment - Bayer
 
Ateesha F. Mohamed
Employment - Bayer
 
Dawn Odom
Employment - RTI Health Solutions
 
Jennifer Bartsch
Employment - RTI Health Solutions
 
Amir Snapir
No Relationships to Disclose
 
Toni Sarapohja
Employment - Orion
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; Lilly